Fresh off raising $1.8M, Chapel Hill startup preps for $8 million
Posted Jan 27, 2017
Chapel Hill-based startup Renovion – which is developing a nebulized therapy called Arina-1 for the treatment of lung transplant patients– has its eyes on submitting a New Drug Application to the U.S. Food and Drug Administration in early 2019, according to chief executive officer Dan Copeland.
(Triangle Business Journal)
Related: Campus Connections
Chapel Hill restaurants foster relationships with UNC athletesBehind name, image, and likeness deals that have encouraged high-profile athletes to consider business sponsorships, smaller restaurants in Chapel Hill have taken a different approach...
Wed Apr 17, 2024ESPN announces 30 for 30 documentary on UNC alum Stuart Scott
ESPN Films will produce a 30 for 30 documentary on the extraordinary life of UNC alum Stuart Scott, who had many fans of the unique...
Mon Apr 15, 2024
‘You don’t see it every day’: Crowds gather at Morehead Planetarium to watch eclipse in Chapel Hill
Crowds of people spent the day at Morehead Planetarium and Science Center in Chapel Hill to take in the solar eclipse. By midafternoon, the moon...
Mon Apr 15, 2024
Green Beret Veteran Returns to Civilian Life as a UNC Student Athlete
Throughout UNC-Chapel Hill’s club hockey season this year, a camo helmet with flashes of gold could be seen moving in and out of the goal...
Sun Apr 14, 2024